Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cidara Therapeutics, Inc. (CDTX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cidara Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1610618.
Total stock buying since 2015: $109,667,432.
Total stock sales since 2015: $373,097.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 2,276,047 | $100,073,883 | 3,437 | $75,481 | 0 | $0 |
| 2024 | 8,000 | $105,680 | 82,928 | $75,662 | 0 | $0 |
| 2023 | 110,000 | $109,449 | 74,818 | $88,882 | 0 | $0 |
| 2022 | 0 | $0 | 76,878 | $57,919 | 50,000 | $0 |
| 2021 | 127,000 | $211,926 | 9,799 | $22,127 | 47,863 | $0 |
| 2020 | 100,000 | $200,699 | 5,514 | $19,223 | 0 | $0 |
| 2019 | 82,500 | $157,357 | 16,120 | $33,803 | 0 | $0 |
| 2018 | 212,766 | $1,000,000 | 0 | $0 | 0 | $0 |
| 2017 | 127,750 | $907,920 | 0 | $0 | 0 | $0 |
| 2016 | 8,666 | $99,832 | 0 | $0 | 0 | $0 |
| 2015 | 426,207 | $6,800,686 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 2,276,047 | $100,073,883 | 0 | $0 | 0 | $0 |
| 2025-03 | 0 | $0 | 3,437 | $75,481 | 0 | $0 |
| 2024-09 | 0 | $0 | 1,833 | $21,331 | 0 | $0 |
| 2024-06 | 8,000 | $105,680 | 0 | $0 | 0 | $0 |
| 2024-03 | 0 | $0 | 81,095 | $54,331 | 0 | $0 |
| 2023-09 | 0 | $0 | 37,262 | $35,323 | 0 | $0 |
| 2023-08 | 60,000 | $57,600 | 0 | $0 | 0 | $0 |
| 2023-03 | 50,000 | $51,849 | 25,742 | $39,383 | 0 | $0 |
| 2023-01 | 0 | $0 | 11,814 | $14,176 | 0 | $0 |
| 2022-09 | 0 | $0 | 68,478 | $48,219 | 50,000 | $0 |
| 2022-03 | 0 | $0 | 1,599 | $1,199 | 0 | $0 |
| 2022-01 | 0 | $0 | 6,801 | $8,501 | 0 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 47,863 | $0 |
| 2021-11 | 70,000 | $110,350 | 0 | $0 | 0 | $0 |
| 2021-09 | 7,000 | $14,826 | 0 | $0 | 0 | $0 |
| 2021-08 | 50,000 | $86,750 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 3,239 | $8,614 | 0 | $0 |
| 2021-01 | 0 | $0 | 6,560 | $13,513 | 0 | $0 |
| 2020-11 | 100,000 | $200,699 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 5,514 | $19,223 | 0 | $0 |
| 2019-10 | 0 | $0 | 10,579 | $20,616 | 0 | $0 |
| 2019-09 | 82,500 | $157,357 | 1,001 | $1,861 | 0 | $0 |
| 2019-03 | 0 | $0 | 4,540 | $11,326 | 0 | $0 |
| 2018-05 | 212,766 | $1,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-26 | Shah Rajeev M. | Buy | 2,272,727 | 44.00 | 99,999,988 |
| 2025-06-03 | Mineo Chrysa (Director) | Buy | 1,050 | 23.44 | 24,614 |
| 2025-06-02 | Mineo Chrysa (Director) | Buy | 2,270 | 21.71 | 49,281 |
| 2025-03-11 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 1,773 | 21.96 | 38,940 |
| 2025-03-11 | Ward Shane (COO & CLO) | Sale | 1,664 | 21.96 | 36,541 |
| 2024-09-11 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 909 | 11.64 | 10,579 |
| 2024-09-11 | Sandison Taylor (Chief Medical Officer) | Sale | 924 | 11.64 | 10,752 |
| 2024-06-07 | Stein Jeffrey (President & CEO) | Buy | 8,000 | 13.21 | 105,680 |
| 2024-03-11 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 21,029 | .67 | 14,089 |
| 2024-03-11 | Shah Preetam (CFO & CBO) | Sale | 18,931 | .67 | 12,683 |
| 2024-03-11 | Sandison Taylor (Chief Medical Officer) | Sale | 20,662 | .67 | 13,843 |
| 2024-03-11 | Ward Shane (COO & CLO) | Sale | 20,473 | .67 | 13,716 |
| 2023-09-11 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 18,469 | .95 | 17,508 |
| 2023-09-11 | Sandison Taylor (Chief Medical Officer) | Sale | 18,793 | .95 | 17,815 |
| 2023-08-14 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Buy | 10,000 | .97 | 9,700 |
| 2023-08-08 | Stein Jeffrey (President & CEO) | Buy | 50,000 | .96 | 47,900 |
| 2023-03-27 | Stein Jeffrey (President & CEO) | Buy | 50,000 | 1.04 | 51,849 |
| 2023-03-13 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 7,562 | 1.53 | 11,569 |
| 2023-03-13 | Shah Preetam (CFO & CBO) | Sale | 6,648 | 1.53 | 10,171 |
| 2023-03-13 | Sandison Taylor (Chief Medical Officer) | Sale | 7,203 | 1.53 | 11,020 |
| 2023-03-13 | Ward Shane (COO & CLO) | Sale | 4,329 | 1.53 | 6,623 |
| 2023-01-12 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 11,814 | 1.20 | 14,176 |
| 2022-09-19 | Shah Preetam (CFO & CBO) | Sale | 15,642 | .77 | 12,028 |
| 2022-09-15 | Shah Preetam (CFO & CBO) | Option Ex | 50,000 | .00 | 0 |
| 2022-09-12 | Tari Leslie (CHIEF SCIENTIFIC OFFICER) | Sale | 18,159 | .69 | 12,438 |
| 2022-09-12 | Sandison Taylor (Chief Medical Officer) | Sale | 18,478 | .69 | 12,657 |
| 2022-09-12 | Daruwala Paul (Chief Operating Officer) | Sale | 16,199 | .69 | 11,096 |
| 2022-03-21 | Johnson Brady (Vice President, Finance) | Sale | 654 | .81 | 529 |
| 2022-03-11 | Johnson Brady (Vice President, Finance) | Sale | 945 | .71 | 670 |
| 2022-01-05 | Tari Leslie (Chief Scientific Officer) | Sale | 1,252 | 1.25 | 1,565 |
| 2022-01-05 | Johnson Brady (Vice President, Finance) | Sale | 416 | 1.25 | 520 |
| 2022-01-05 | Daruwala Paul (Chief Operating Officer) | Sale | 5,133 | 1.25 | 6,416 |
| 2021-12-29 | Tari Leslie (Chief Scientific Officer) | Option Ex | 2,101 | .00 | 0 |
| 2021-12-29 | Johnson Brady (Vice President, Finance) | Option Ex | 262 | .00 | 0 |
| 2021-12-29 | Sandison Taylor (Chief Medical Officer) | Option Ex | 15,600 | .00 | 0 |
| 2021-12-29 | Daruwala Paul (Chief Operating Officer) | Option Ex | 9,900 | .00 | 0 |
| 2021-12-29 | Stein Jeffrey (President & CEO) | Option Ex | 20,000 | .00 | 0 |
| 2021-11-12 | Shah Preetam (CFO & CBO) | Buy | 20,000 | 1.54 | 30,800 |
| 2021-11-12 | Stein Jeffrey (President & CEO) | Buy | 50,000 | 1.59 | 79,550 |
| 2021-09-13 | Franson Timothy R | Buy | 7,000 | 2.12 | 14,826 |
| 2021-08-19 | Stein Jeffrey (President & CEO) | Buy | 10,000 | 1.79 | 17,870 |
| 2021-08-18 | Stein Jeffrey (President & CEO) | Buy | 40,000 | 1.72 | 68,880 |
| 2021-04-01 | Oien Jessica (General Counsel & Secretary) | Sale | 1,177 | 2.66 | 3,130 |
| 2021-04-01 | Abdollahian Neil (Chief Business Officer) | Sale | 1,469 | 2.66 | 3,907 |
| 2021-04-01 | Daruwala Paul (Chief Operating Officer) | Sale | 593 | 2.66 | 1,577 |
| 2021-01-05 | Oien Jessica (General Counsel & Secretary) | Sale | 824 | 2.06 | 1,697 |
| 2021-01-05 | Abdollahian Neil (Chief Business Officer) | Sale | 2,868 | 2.06 | 5,908 |
| 2021-01-05 | Daruwala Paul (Chief Operating Officer) | Sale | 2,868 | 2.06 | 5,908 |
| 2020-11-10 | Stein Jeffrey (President & CEO) | Buy | 50,000 | 2.00 | 100,000 |
| 2020-11-10 | Levine James E. (Chief Financial Officer) | Buy | 50,000 | 2.01 | 100,699 |
| 2020-01-03 | Abdollahian Neil (Chief Business Officer) | Sale | 2,340 | 3.42 | 8,002 |
| 2020-01-03 | Daruwala Paul (Chief Operating Officer) | Sale | 2,340 | 3.42 | 8,002 |
| 2020-01-02 | Oien Jessica (General Counsel & Secretary) | Sale | 834 | 3.86 | 3,219 |
| 2019-10-02 | Daruwala Paul (Chief Operating Officer) | Sale | 3,295 | 1.88 | 6,194 |
| 2019-10-01 | Abdollahian Neil (Chief Business Officer) | Sale | 7,284 | 1.98 | 14,422 |
| 2019-09-27 | Oien Jessica (General Counsel & Secretary) | Sale | 1,001 | 1.86 | 1,861 |
| 2019-09-24 | Stein Jeffrey (President & CEO) | Buy | 52,500 | 1.91 | 100,117 |
| 2019-09-24 | Levine James E. (Chief Financial Officer) | Buy | 30,000 | 1.91 | 57,240 |
| 2019-03-08 | Abdollahian Neil (Chief Business Officer) | Sale | 2,300 | 2.44 | 5,612 |
| 2019-03-07 | Daruwala Paul (Chief Operating Officer) | Sale | 2,240 | 2.55 | 5,714 |
| 2018-05-23 | Stein Jeffrey (President & CEO) | Buy | 212,766 | 4.70 | 1,000,000 |
| 2017-11-15 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 7.57 | 453,960 |
| 2017-09-12 | Stein Jeffrey (President & CEO) | Buy | 7,350 | 6.79 | 49,906 |
| 2017-06-07 | Sandison Taylor (Chief Medical Officer) | Buy | 19,344 | 5.90 | 114,129 |
| 2017-06-06 | Sandison Taylor (Chief Medical Officer) | Buy | 656 | 5.90 | 3,870 |
| 2017-06-05 | Stein Jeffrey (President & CEO) | Buy | 15,000 | 5.95 | 89,205 |
| 2017-03-31 | Forrest Kevin (Chief Scientific Officer) | Buy | 12,500 | 7.75 | 96,875 |
| 2017-03-31 | Stein Jeffrey (President & CEO) | Buy | 12,900 | 7.75 | 99,975 |
| 2016-05-20 | Forrest Kevin (COO & CFO) | Buy | 4,356 | 11.53 | 50,224 |
| 2016-05-20 | Stein Jeffrey (President & CEO) | Buy | 4,310 | 11.51 | 49,608 |
| 2015-11-25 | Stein Jeffrey (President & CEO) | Buy | 1,300 | 15.60 | 20,280 |
| 2015-11-24 | Stein Jeffrey (President & CEO) | Buy | 5,400 | 14.97 | 80,838 |
| 2015-11-23 | Forrest Kevin (COO & CFO) | Buy | 7,087 | 14.23 | 100,848 |
| 2015-04-20 | Stein Jeffrey (President & CEO) | Buy | 420 | 16.00 | 6,720 |
| 2015-04-20 | Franson Timothy R (Director) | Buy | 4,000 | 16.00 | 64,000 |
| 2015-04-20 | Kjellson Nina S (Director) | Buy | 200,000 | 16.00 | 3,200,000 |
| 2015-04-20 | Heron Patrick J (Director) | Buy | 200,000 | 16.00 | 3,200,000 |
| 2015-04-20 | Perez Robert J (Director) | Buy | 5,000 | 16.00 | 80,000 |
| 2015-04-20 | Burgess Daniel D (Director) | Buy | 3,000 | 16.00 | 48,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CDTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cidara Therapeutics, Inc. (symbol CDTX, CIK number 1610618) see the Securities and Exchange Commission (SEC) website.